Peter Brossart
C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer.
Klümper N, Saal J, Berner F, Lichtensteiger C, Wyss N, Heine A, Bauernfeind F, Ellinger J, Brossart P, Diem S, Schmid S, Jörger M, Frueh M, Ritter M, Hölzel M, Flatz L, Bald T. C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer. J Immunother Cancer 2022; 10
Mar 1, 2022C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer.
Mar 1, 2022J Immunother Cancer 2022; 10
Klümper Niklas, Saal Jonas, Berner Fiamma, Lichtensteiger Christa, Wyss Nina, Heine Annkristin, Bauernfeind Franz Georg, Ellinger Jörg, Brossart Peter, Diem Stefan, Schmid Sabine, Jörger Markus, Frueh Martin, Ritter Manuel, Hölzel Michael, Flatz Lukas, Bald Tobias
Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
Bilich T, Flatz L, Held S, Brossart P, Märklin M, Wagner P, Erne E, Klein R, Rammensee H, Salih H, Berner F, Wacker M, Roerden M, Maringer Y, Nelde A, Heitmann J, Dubbelaar M, Peter A, Hörber S, Bauer J, Rieth J, Walz J. Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer. Cancer Discov 2021; 11:1982-1995.
May 19, 2021Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
May 19, 2021Cancer Discov 2021; 11:1982-1995
Bilich Tatjana, Flatz Lukas, Held Stefanie, Brossart Peter, Märklin Melanie, Wagner Philipp, Erne Eva, Klein Reinhild, Rammensee Hans-Georg, Salih Helmut R, Berner Fiamma, Wacker Marcel, Roerden Malte, Maringer Yacine, Nelde Annika, Heitmann Jonas S, Dubbelaar Marissa L, Peter Andreas, Hörber Sebastian, Bauer Jens, Rieth Jonas, Walz Juliane S
Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma
Fröhlich A, Ring S, Golletz C, Pietsch T, Strieth S, Brossart P, Gielen G, Kristiansen G, Bootz F, Landsberg J, Flatz L, Hoffmann F, Sirokay J, Fietz S, Vogt T, Dietrich J, Zarbl R, Florin M, Kuster P, Saavedra G, Valladolid S, Dietrich D. Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma. EBioMedicine 2020; 59:102962.
Aug 30, 2020Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma
Aug 30, 2020EBioMedicine 2020; 59:102962
Fröhlich Anne, Ring Sandra, Golletz Carsten, Pietsch Torsten, Strieth Sebastian, Brossart Peter, Gielen Gerrit H, Kristiansen Glen, Bootz Friedrich, Landsberg Jennifer, Flatz Lukas, Hoffmann Friederike, Sirokay Judith, Fietz Simon, Vogt Timo J, Dietrich Jörn, Zarbl Romina, Florin Mike, Kuster Pia, Saavedra Gonzalo, Valladolid Susana Ramírez, Dietrich Dimo
Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma
Hoffmann F, Landsberg J, Kristiansen G, Flatz L, Pietsch T, Dietrich J, Ring S, Gielen G, Strieth S, Kuster P, Saavedra G, Brossart P, Holderried T, Posch C, Fröhlich A, Sirokay J, Niebel D, Zarbl R, Dietrich D. Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma. Clin Epigenetics 2020; 12:94.
Jun 26, 2020Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma
Jun 26, 2020Clin Epigenetics 2020; 12:94
Hoffmann Friederike, Landsberg Jennifer, Kristiansen Glen, Flatz Lukas, Pietsch Torsten, Dietrich Jörn, Ring Sandra, Gielen Gerrit H, Strieth Sebastian, Kuster Pia, Saavedra Gonzalo, Brossart Peter, Holderried Tobias A W, Posch Christian, Fröhlich Anne, Sirokay Judith, Niebel Dennis, Zarbl Romina, Dietrich Dimo
Imatinib mesylate and nilotinib affect MHC-class I presentation by modulating the proteasomal processing of antigenic peptides
Held S, Brossart P, Driessen C, Schild H, Kurts C, Bringmann A, von Schwarzenberg K, Rückrich T, Tenzer S, Duchardt K, Heine A. Imatinib mesylate and nilotinib affect MHC-class I presentation by modulating the proteasomal processing of antigenic peptides. Cancer Immunol Immunother 2012; 62:715-26.
Nov 25, 2012Imatinib mesylate and nilotinib affect MHC-class I presentation by modulating the proteasomal processing of antigenic peptides
Nov 25, 2012Cancer Immunol Immunother 2012; 62:715-26
Held Stefanie Andrea Erika, Brossart Peter, Driessen Christoph, Schild Hansjörg, Kurts Christian, Bringmann Anita, von Schwarzenberg Karin, Rückrich Thomas, Tenzer Stefan, Duchardt Katharina Maria, Heine Annkristin
IL-4-mediated fine tuning of IL-12p70 production by human DC
Guenova E, Röcken M, Brossart P, Schwärzler C, Chen K, Wölbing F, Müller M, Kaesler S, Sauer K, Volz T, Biedermann T. IL-4-mediated fine tuning of IL-12p70 production by human DC. Eur J Immunol 2008; 38:3138-49.
Nov 1, 2008IL-4-mediated fine tuning of IL-12p70 production by human DC
Nov 1, 2008Eur J Immunol 2008; 38:3138-49
Guenova Emmanuella, Röcken Martin, Brossart Peter, Schwärzler Christoph, Chen KoMing, Wölbing Florian, Müller Martin R, Kaesler Susanne, Sauer Karin, Volz Thomas, Biedermann Tilo